Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group
- Author
- SKARLOS, Dimosthenis V1 ; BAI, Maria2 ; GOUSSIA, Anna2 ; SAMANTAS, Epaminontas3 ; GALANI, Eleni1 ; TSAVDARIDIS, Dimitrios4 ; KARINA, Maria5 ; PAPAKOSTAS, Pavlos6 ; KONSTANTARA, Athina5 ; FOUNTZILAS, George5
[1] Henry Dunant Hospital, Athens, Greece
[2] Ioannina Hospital, University of Ioannina School of Medicine, Ioannina, Greece
[3] Agii Anargiri Cancer Hospital, Athens, Greece
[4] IKA Hospital, Thessaloniki, Greece
[5] Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
[6] Ippokration Hospital, Athens, Greece - Source
Anticancer research. 2007, Vol 27, Num 4C, pp 2973-2983, 11 p ; ref : 37 ref
- ISSN
- 0250-7005
- Scientific domain
- Medical oncology
- Publisher
- International Institute of Anticancer Research, Attiki
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- Gastric cancer molecular tumor markers post-operative chemotherapy
- Keyword (fr)
- Anticancéreux Cancer estomac Cancérologie Chimiothérapie Docétaxel Homme Irinotécan Marqueur génétique Marqueur moléculaire Marqueur tumoral Postopératoire Pronostic Traitement Tumeur maligne Camptothécine dérivé Inhibiteur de la topoisomérase I Antimitotique Appareil digestif pathologie DNA topoisomerase Enzyme Estomac pathologie Inhibiteur enzyme Isomerases Taxane dérivé
- Keyword (en)
- Antineoplastic agent Stomach cancer Cancerology Chemotherapy Docetaxel Human Irinotecan Genetic marker Molecular marker Tumoral marker Postoperative Prognosis Treatment Malignant tumor Antimitotic Digestive diseases DNA topoisomerase Enzyme Gastric disease Enzyme inhibitor Isomerases Taxane derivatives
- Keyword (es)
- Anticanceroso Cáncer del estómago Cancerología Quimioterapia Docetaxel Hombre Irinotecán Marcador genético Marcador molecular Marcador tumoral Postoperatorio Pronóstico Tratamiento Tumor maligno Antimitótico Aparato digestivo patología DNA topoisomerase Enzima Estómago patología Inhibidor enzima Isomerases Taxane derivado
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18962773
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"4C\";s:8:\"\u0000*\u0000spage\";s:4:\"2973\";s:8:\"\u0000*\u0000epage\";s:4:\"2983\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SKARLOS\";s:10:\"\u0000*\u0000aufirst\";s:13:\"Dimosthenis V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BAI, Maria\";i:1;s:13:\"GOUSSIA, Anna\";i:2;s:21:\"SAMANTAS, Epaminontas\";i:3;s:13:\"GALANI, Eleni\";i:4;s:22:\"TSAVDARIDIS, Dimitrios\";i:5;s:13:\"KARINA, Maria\";i:6;s:18:\"PAPAKOSTAS, Pavlos\";i:7;s:19:\"KONSTANTARA, Athina\";i:8;s:18:\"FOUNTZILAS, George\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"4C\";s:8:\"\u0000*\u0000spage\";s:4:\"2973\";s:8:\"\u0000*\u0000epage\";s:4:\"2983\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SKARLOS\";s:10:\"\u0000*\u0000aufirst\";s:13:\"Dimosthenis V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BAI, Maria\";i:1;s:13:\"GOUSSIA, Anna\";i:2;s:21:\"SAMANTAS, Epaminontas\";i:3;s:13:\"GALANI, Eleni\";i:4;s:22:\"TSAVDARIDIS, Dimitrios\";i:5;s:13:\"KARINA, Maria\";i:6;s:18:\"PAPAKOSTAS, Pavlos\";i:7;s:19:\"KONSTANTARA, Athina\";i:8;s:18:\"FOUNTZILAS, George\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"4C\";s:8:\"\u0000*\u0000spage\";s:4:\"2973\";s:8:\"\u0000*\u0000epage\";s:4:\"2983\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SKARLOS\";s:10:\"\u0000*\u0000aufirst\";s:13:\"Dimosthenis V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BAI, Maria\";i:1;s:13:\"GOUSSIA, Anna\";i:2;s:21:\"SAMANTAS, Epaminontas\";i:3;s:13:\"GALANI, Eleni\";i:4;s:22:\"TSAVDARIDIS, Dimitrios\";i:5;s:13:\"KARINA, Maria\";i:6;s:18:\"PAPAKOSTAS, Pavlos\";i:7;s:19:\"KONSTANTARA, Athina\";i:8;s:18:\"FOUNTZILAS, George\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"4C\";s:8:\"\u0000*\u0000spage\";s:4:\"2973\";s:8:\"\u0000*\u0000epage\";s:4:\"2983\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SKARLOS\";s:10:\"\u0000*\u0000aufirst\";s:13:\"Dimosthenis V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BAI, Maria\";i:1;s:13:\"GOUSSIA, Anna\";i:2;s:21:\"SAMANTAS, Epaminontas\";i:3;s:13:\"GALANI, Eleni\";i:4;s:22:\"TSAVDARIDIS, Dimitrios\";i:5;s:13:\"KARINA, Maria\";i:6;s:18:\"PAPAKOSTAS, Pavlos\";i:7;s:19:\"KONSTANTARA, Athina\";i:8;s:18:\"FOUNTZILAS, George\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"4C\";s:8:\"\u0000*\u0000spage\";s:4:\"2973\";s:8:\"\u0000*\u0000epage\";s:4:\"2983\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SKARLOS\";s:10:\"\u0000*\u0000aufirst\";s:13:\"Dimosthenis V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BAI, Maria\";i:1;s:13:\"GOUSSIA, Anna\";i:2;s:21:\"SAMANTAS, Epaminontas\";i:3;s:13:\"GALANI, Eleni\";i:4;s:22:\"TSAVDARIDIS, Dimitrios\";i:5;s:13:\"KARINA, Maria\";i:6;s:18:\"PAPAKOSTAS, Pavlos\";i:7;s:19:\"KONSTANTARA, Athina\";i:8;s:18:\"FOUNTZILAS, George\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:192:\"Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
